Elekta AB (publ) (EKTAY)
OTCMKTS · Delayed Price · Currency is USD
6.11
+0.02 (0.33%)
Dec 31, 2025, 4:00 PM EST
Elekta AB Market Cap
Elekta AB has a market cap or net worth of $2.36 billion as of January 2, 2026. Its market cap has increased by 5.41% in one year.
Market Cap
2.36B
Enterprise Value
2.91B
Revenue
1.85B
Ranking
n/a
PE Ratio
76.73
Stock Price
$6.11
Market Cap Chart
Since September 4, 1997, Elekta AB's market cap has increased from 191.46M to 2.36B, an increase of 1,132.22%. That is a compound annual growth rate of 9.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 2.36B | 11.52% |
| Dec 30, 2024 | 2.12B | -32.17% |
| Dec 29, 2023 | 3.12B | 35.48% |
| Dec 30, 2022 | 2.30B | -52.43% |
| Dec 30, 2021 | 4.84B | -6.05% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.80M |
| Glass House Brands | 710.35M |
| Elite Pharmaceuticals | 526.74M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| Northwest Biotherapeutics | 356.97M |
| CytoDyn | 355.55M |
| Silence Therapeutics | 287.18M |